Katie Cinnamon, PharmD, BCPS, BCIDP

Excited to share our work (just in time for URI season!) implementing order sentence favorites for URI supportive care as an effective way to reduce outpatient abx prescribing, especially in Tier 3 diagnoses. Shout out to our incredible Amb Care team for partnering to implement this intervention!

So honored to be part of this group 🙌

@steventong.bsky.social presents the results of the PSSA domain of the SNAP 🫰 trial - the worlds largest trial of staph aureus bacteremia - at #ESCMID2025

fluclox resulted in higher mortality and more AKI compared to penicillin for PSSA

Want to know if you can safely use linezolid or tedizolid beyond 10 to 14 days? Dr. @pharmermeg.bsky.social has the answers at #ESCMIDGlobal 2025!

Key findings: No thrombocytopenia with long-term tedizolid even in high-risk pts and minimal TCP risk with long-term linezolid in low-risk pts. 💊

Vancomycin Taper trial presented by @dremilymcd.bsky.social #ESCMID2025. In people who get better by day 10 should we stop or give taper? Reduced recurrences by primary outcome timepoint but the KM suggests it may be just delaying rather than truly preventing recurrence? #IDSky

🚀 Learn from Dr. McCreary at #MADID2025 about developing effective collaborations between antimicrobial stewardship teams and microbiology laboratories!🔬💊✨

Register today! mad-idmembership.vfairs.com 🗓️

@erinmccreary.bsky.social
@sidpharm.bsky.social
@sheaepi.bsky.social
@accpinfdprn.bsky.social

🚀 Learn from Dr. Wagner at #MADID2025 about ways to enhance efficiency of antimicrobial stewardship programs and explore interprofessional team dynamics! 💊✨

Register today! mad-idmembership.vfairs.com 🗓️

@jamiewagner.bsky.social
@sidpharm.bsky.social
@sheaepi.bsky.social
@accpinfdprn.bsky.social

🔍 Missed key updates in infectious diseases? Drs. Zahra Kassamali Escobar & Jamie L. Wagner have you covered at #MADID2025! 📢

Register now! 👉 mad-idmembership.vfairs.com 🗓️

@zkepharmd.bsky.social
@jamiewagner.bsky.social
@sidpharm.bsky.social
@sheaepi.bsky.social
@accpinfdprn.bsky.social

happy #InternationalWomensDay to the endless sea of incredible women out there 👑

thank you @cmicomms.bsky.social @angelahuttner.bsky.social @anniejoseph.bsky.social for the safe space for this important conversation and our allies Nav, Marc, Josh, and Thomas!

We can’t forget about our patients! #allergydelabeling can improve #QOL with more work to be done to further support these findings
#antimicrobials2025
#amssky #idsky
@elisemitri.bsky.social

Aztreonam-avibactam (Emblaveo) Aztreonam-avibactam (Emblaveo) photo source pfizer.nl KEY POINTS Aztreonam-avibactam (Emblaveo) is the combination of aztreonam (a monobactam) that interferes with bacterial cell wall synthesis and av...

📝 Here are cliff notes on the new FDA-approved product #Emblaveo

www.idstewardship.com/drugs/aztreo...

💠 IV only
💠 Activity vs Ambler Class B metallo-beta-lactamase (MBL) producing gram negative bacteria (e.g., NDM)
💠 Likely will be expensive
💠 Has been approved in Europe since April 2024

#IDsky

Breaking news🔥
US FDA approves EMBLAVEO (aztreonam and avibactam) for complicated intra-abdominal infections (cIAI) in adult patients who have limited or no alternative options #idsky

What’s Hot This Year in ID Clinical Science This review covers important public health notices and clinical trials covering a broad range of infectious diseases topics from October 2023 to September

2024 was a 🔥 year in ID
🆕💫 @cidjournal.bsky.social
What’s Hot This Year in ID Clinical Science
The review highlights some of the most important trials and clinical trends in infectious diseases over the past year #idsky
academic.oup.com/cid/advance-...

come join us in beautiful Madison,WI (one of the birthplaces of PK/PD!) for @sidpharm.bsky.social PKPD Workshop, in partnership with our @escmid.bsky.social PKPD study group friends
Register: sidp.org/event-5963379
pharms, physicians, scientists, trainees, etc - ALL WELCOME
#medsky #idsky #amssky

How accurate is ceftriaxone at predicting susceptibility of enterobacterales isolates to oral higher-generation cephalosporins? | Antimicrobial Agents and Chemotherapy There is a growing body of evidence supporting early transition to oral antibiotic therapy to complete treatment courses for gram-negative bloodstream infections (GN-BSI) (1–3). Most available data fo...

Happy New Year, @absteward.bsky.social style! 🎉
Kicking off 2025 with this gem:
🆕💫 How accurate is ceftriaxone at predicting susceptibility of enterobacterales isolates to oral higher-generation cephalosporins? #idsky #EMIMCC
journals.asm.org/doi/10.1128/...

Pulm empyema and multiple brain abscesses- was on TMP/Sulfa + Linezolid but possible SIADH and worsening myelosuppression on planned 6+ week course and recent switch to Moxi/Sulfadiazine.

Great to see the CACTUS study in print! authors.elsevier.com/c/1kHGc5E-Uo... Ceftaz-avi vs. Ceftol-tazo for MDR Pseudomonas. Tremendous effort by all involved, and thanks to a great leadership team. The PRECEDENT network is cooking up much more, check it out at www.precedentnetwork.com! #IDsky

Polling #IDSky! Anyone have experience timing/analyzing sulfonamide peak lvl for pt on sulfadiazine with Nocardiosis (intolerance to TMP/Sulfa)? Seems like time to peak more delayed - time 3-4 hrs (vs 2hr w/ TMP/sulfa)? Anyone aware of PK lit correlating peak w/ efficacy vs tox for sulfadiazine?

Year In Review: Top Infectious Diseases Articles From 2024 In this article a selection of notable peer-reviewed publications from 2024 are provided. Article Selection by: Bassam Ghanem, Pharm.D., MS, BCPS Article Construction by: Timothy P. Gauthier, Pharm.D....

🔥🔥 NEW 🔥🔥
Year In Review: Top Infectious Diseases Articles From 2024
Our new post, a great collaboration with my friend
🌟 @idstewardship.bsky.social
1️⃣6️⃣⚡️🆔 RCTs
7️⃣Syst Reviews/Meta
3️⃣🌏Guidelines ✨️Wiki_Guidelines
#idsky #EMIMCC #medsky #utisky
EnJoy
Share plz!
www.idstewardship.com/year-review-...

🔥 New in ASHE www.cambridge.org/core/journal...

I’d post the summary text but @bsky.app text limits are too restrictive. #IDsky

we updated our metronidazole dosing across UPMC system over a year ago based on Sunish's prelim work and now the final evaluation is published! so proud of him!! #idsky #amssky #pharmsky #medsky

www.sciencedirect.com/science/arti...

it’s the happiest Thursday because @sidpharm.bsky.social and the @escmid.bsky.social PK PD study group are bringing back ICAAC (in spirit)!!!!

Registration will open next week! The Midwest in the summer is magical - come join us!

sidp.org/page-1543694

#idsky #amssky #pharmsky

https://www.cognitoforms.com/SIDP1/_2025SocietyPlanningSurvey

🚨📣 @sidpharm.bsky.social the Board and Programs Committee want to hear from you! Please take 2 minutes to fill out the member survey for 2025 planning before Friday: www.cognitoforms.com/SIDP1/_2025S...

The Four Moments of Antibiotic Decision Making
Random image #idsky #medsky #AMSsky

🆕 #Breakpoints Episode: Drs. @annegretemartson.bsky.social, Megan Wimmer, and Evan Clemens join me to discuss all things (Val)ganciclovir!!! #idsky #pharmsky #amssky @sidpharm.bsky.social

🎧 sidp.pinecast.co

🆕️🔥Article @thetxidjournal.bsky.social
Not Just an Oxymoron: The Utilitarian's Guide to Antimicrobial Stewardship in Transplant Infectious Diseases
Table ✨️2: TID ASP opportunities & initiatives
#idsky #medsky #Txid
onlinelibrary.wiley.com/doi/full/10....

Current Pyuria Cutoffs Promote Inappropriate Urinary Tract Infection Diagnosis in Older Women The degree of pyuria can help distinguish urinary tract infection (UTI) in older women from asymptomatic women with and without bacteriuria. We demonstrate

Meant to share this study by @merellambregts.bsky.social's team
@cjcrnich.bsky.social 😊 when you & I were on #Breakpoints we were asked whether there was a pyuria cutoff to help differentiate btw infection & colonization
Here may be one (in elderly ♀️ at least) #IDSky
academic.oup.com/cid/article/...

Graphical abstract for the article "State-of-the-Art Review: Ocular Infections"

New in @cidjournal.bsky.social

State-of-the-Art Review: Ocular Infections

Miriam Barshak and multidisciplinary team

#IDSky #OphthoSky #MedSky @nottheogdrv.bsky.social

academic.oup.com/cid/article/...

Adult penicillin allergy programmes in Australian hospitals: a practical guide from the National Antibiotic Allergy Network - PubMed Penicillin allergy is a significant burden on patient, prescribing and hospital outcomes. There has been increasing interest in the incorporation of penicillin allergy testing (i.e. delabelling) into ...

Thought worth a share on #WAAW @ncas.bsky.social day today. A practical guide to #penicillinallergy into inpatient #AMS programs. A partner to implementation! #IDSky #MedSky
pubmed.ncbi.nlm.nih.gov/39444148/

🔥Everyone's favorite #shorterisbetter table is updated🔥
"BALANCE is now published,
so the table is now updated!
GNB bacteremia is now listed as Bacteremia(non S.aureus)
Neary 5,000 patients have now been randomized to 1 vs. 2 Constantine Units for non S. aureus bacteremia " Dr.Spellberg #idsky